← Back to Clinical Trials
Recruiting NCT07071207

NCT07071207 Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07071207
Status Recruiting
Phase
Sponsor University of Rochester
Condition Incontinence, Urinary Stress
Study Type INTERVENTIONAL
Enrollment 132 participants
Start Date 2025-09-15
Primary Completion 2028-05-01

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Text message reminders

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 132 participants in total. It began in 2025-09-15 with a primary completion date of 2028-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Eligibility Criteria

Inclusion Criteria: 1. Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure 2. Patient of URMC Urology 3. Adult male 18 years of age and older 4. Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted) 5. Has access to a mobile device capable of receiving automated text messages. 6. Willing to receive text messages and to complete questionnaires via SMS text. 7. Willingness to participate and able to provide informed consent. Exclusion Criteria: 1. Less than 18 years of age 2. Unable to send and receive SMS texts 3. Unable to read, write, and speak English 4. Catheter dependency 5. Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period 6. In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.

Contact & Investigator

Central Contact

Austin Jackson

✉ Austin_jackson@urmc.rochester.edu

📞 (585) 275-0126

Frequently Asked Questions

Who can join the NCT07071207 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Incontinence, Urinary Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07071207 currently recruiting?

Yes, NCT07071207 is actively recruiting participants. Contact the research team at Austin_jackson@urmc.rochester.edu for enrollment information.

Where is the NCT07071207 trial being conducted?

This trial is being conducted at Rochester, United States.

Who is sponsoring the NCT07071207 clinical trial?

NCT07071207 is sponsored by University of Rochester. The trial plans to enroll 132 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology